Skip to content

Accordant Advisory Group Inc: RRC position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Accordant Advisory Group Inc on RRC, newest first. How the timeline and the estimate are built.

Accordant Advisory Group Inc held 43,820 RRC shares at 2026-06-30 per its 13F-HR filed 2026-07-27.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 43,820 shares
    Change vs previous 13F -142 shares

    1.1% of the 13F portfolio, value $1,629,666.

    13F-HR 0002013499-26-000003 filed by Accordant Advisory Group Inc
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 43,962 shares
    Change vs previous 13F +1,668 shares

    1.23% of the 13F portfolio, value $1,986,204.

    13F-HR 0002013499-26-000002 filed by Accordant Advisory Group Inc
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 42,294 shares
    Change vs previous 13F +1,631 shares

    1.03% of the 13F portfolio, value $1,491,287.

    13F-HR 0002013499-26-000001 filed by Accordant Advisory Group Inc
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 40,663 shares
    Change vs previous 13F +1,067 shares

    1.04% of the 13F portfolio, value $1,530,556.

    13F-HR 0002013499-25-000009 filed by Accordant Advisory Group Inc
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 39,596 shares
    Change vs previous 13F not available

    1.2% of the 13F portfolio, value $1,610,370.

    13F-HR 0002013499-25-000007 filed by Accordant Advisory Group Inc
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).